Matches in SemOpenAlex for { <https://semopenalex.org/work/W2337557959> ?p ?o ?g. }
- W2337557959 endingPage "229" @default.
- W2337557959 startingPage "209" @default.
- W2337557959 abstract "The therapeutic goals in metastatic breast cancer (MBC) remain palliative in nature, aimed at controlling symptoms, improving or maintaining quality of life and prolonging survival. The advent of new drugs and new formulations of standard agents has led to better outcomes in patients with advanced or metastatic disease. These developments have also allowed a tailored therapeutic approach, in which the molecular biology of the tumour, the treatment history, and patient attitudes are taken into account in the decision-making process. Targeting drug delivery to the tumour is a promising mean of increasing the therapeutic index of highly active agents such as the taxanes, and nanoparticle albumin-bound paclitaxel (nab-paclitaxel), the first nanotechnology-based drug developed in cancer treatment, is one such advance. Data from randomized trials support the efficacy of single-agent nab-paclitaxel as first-line and further treatment lines in MBC at the registered 3-weekly schedule of 260 mg/m(2), but emerging evidence suggests its activity as a weekly regimen or combined with other agents in various clinical scenarios. Thus, nab-paclitaxel seems to offer flexibility in terms of dosing schedules, allowing physicians to tailor the dose according to different clinical situations. This paper reviews the clinical trial background for nab-paclitaxel in MBC, focusing on specific 'difficult-to-treat' patient populations, such as taxane-pretreated or elderly women, as well as those with triple-negative, HER2-positive and poor-prognostic-factors disease. Moving beyond evidence-based information, 'real life' available experiences are also discussed with the aim of providing an update for daily clinical practice." @default.
- W2337557959 created "2016-06-24" @default.
- W2337557959 creator A5038515367 @default.
- W2337557959 creator A5045450050 @default.
- W2337557959 creator A5073649680 @default.
- W2337557959 date "2016-04-19" @default.
- W2337557959 modified "2023-09-27" @default.
- W2337557959 title "Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (<i>nab</i>-paclitaxel) in metastatic breast cancer: which benefit for which patients?" @default.
- W2337557959 cites W1484277819 @default.
- W2337557959 cites W1566131907 @default.
- W2337557959 cites W1596105818 @default.
- W2337557959 cites W1605523334 @default.
- W2337557959 cites W1612286138 @default.
- W2337557959 cites W1753522318 @default.
- W2337557959 cites W1935541780 @default.
- W2337557959 cites W1969353138 @default.
- W2337557959 cites W1970168920 @default.
- W2337557959 cites W1975935257 @default.
- W2337557959 cites W1984860352 @default.
- W2337557959 cites W1990280857 @default.
- W2337557959 cites W1991070664 @default.
- W2337557959 cites W1995153811 @default.
- W2337557959 cites W1995224853 @default.
- W2337557959 cites W1997224885 @default.
- W2337557959 cites W2004163315 @default.
- W2337557959 cites W2004810272 @default.
- W2337557959 cites W2006416360 @default.
- W2337557959 cites W2010468882 @default.
- W2337557959 cites W2015181434 @default.
- W2337557959 cites W2015294539 @default.
- W2337557959 cites W2016532947 @default.
- W2337557959 cites W2019305724 @default.
- W2337557959 cites W2021116311 @default.
- W2337557959 cites W2021221739 @default.
- W2337557959 cites W2021597940 @default.
- W2337557959 cites W2022678011 @default.
- W2337557959 cites W2023342930 @default.
- W2337557959 cites W2028242534 @default.
- W2337557959 cites W2033274910 @default.
- W2337557959 cites W2037900100 @default.
- W2337557959 cites W2037999876 @default.
- W2337557959 cites W2038716828 @default.
- W2337557959 cites W2046118760 @default.
- W2337557959 cites W2046516625 @default.
- W2337557959 cites W2059286998 @default.
- W2337557959 cites W2060597541 @default.
- W2337557959 cites W2061239263 @default.
- W2337557959 cites W2064087555 @default.
- W2337557959 cites W2066558863 @default.
- W2337557959 cites W2070897543 @default.
- W2337557959 cites W2073461728 @default.
- W2337557959 cites W2073716382 @default.
- W2337557959 cites W2073961237 @default.
- W2337557959 cites W2078775260 @default.
- W2337557959 cites W2084416824 @default.
- W2337557959 cites W2084535944 @default.
- W2337557959 cites W2092981846 @default.
- W2337557959 cites W2094011365 @default.
- W2337557959 cites W2096738564 @default.
- W2337557959 cites W2099382677 @default.
- W2337557959 cites W2100826058 @default.
- W2337557959 cites W2101485991 @default.
- W2337557959 cites W2102118972 @default.
- W2337557959 cites W2102880631 @default.
- W2337557959 cites W2111970355 @default.
- W2337557959 cites W2112640841 @default.
- W2337557959 cites W2115401462 @default.
- W2337557959 cites W2116267521 @default.
- W2337557959 cites W2117972559 @default.
- W2337557959 cites W2124451657 @default.
- W2337557959 cites W2127287298 @default.
- W2337557959 cites W2127904569 @default.
- W2337557959 cites W2128726450 @default.
- W2337557959 cites W2128941584 @default.
- W2337557959 cites W2131994307 @default.
- W2337557959 cites W2136451551 @default.
- W2337557959 cites W2136791645 @default.
- W2337557959 cites W2140634848 @default.
- W2337557959 cites W2141546964 @default.
- W2337557959 cites W2148109926 @default.
- W2337557959 cites W2148858542 @default.
- W2337557959 cites W2148962662 @default.
- W2337557959 cites W2152976684 @default.
- W2337557959 cites W2153017356 @default.
- W2337557959 cites W2154985964 @default.
- W2337557959 cites W2157333957 @default.
- W2337557959 cites W2158133583 @default.
- W2337557959 cites W2162622637 @default.
- W2337557959 cites W2164934025 @default.
- W2337557959 cites W2165819904 @default.
- W2337557959 cites W2166463482 @default.
- W2337557959 cites W2169073956 @default.
- W2337557959 cites W2169281147 @default.
- W2337557959 cites W2169961966 @default.
- W2337557959 cites W2170602872 @default.
- W2337557959 cites W2171057065 @default.
- W2337557959 cites W2176381659 @default.
- W2337557959 cites W2178665864 @default.